Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/09/2014 | WO2014163445A1 Method for manufacturing gastric cancer prognosis prediction model |
10/09/2014 | WO2014163425A1 Method for producing reprogrammed derivative neuronal stem cell from non-neuronal cell by using hmga2 |
10/09/2014 | WO2014163225A1 Nucleic acid amplification method using allele-specific reactive primer |
10/09/2014 | WO2014163176A1 Method for producing ny-eso-1 protein |
10/09/2014 | WO2014163174A1 Glucuronyl transferase, gene encoding same, and use thereof |
10/09/2014 | WO2014163101A1 Fc region variant |
10/09/2014 | WO2014162962A1 Tumor antigen peptide |
10/09/2014 | WO2014162102A1 Novel mycobacterium tuberculosis target and use thereof in the screening of anti-tuberculosis drugs |
10/09/2014 | WO2014162063A1 Production of acid(s) and alcohol from sugars using yeast |
10/09/2014 | WO2014162031A1 Recombinant vectors based on the modified vaccinia ankara virus (mva) as preventive and therapeutic vaccines against hepatitis c |
10/09/2014 | WO2014161987A1 Polypeptides having dextranase activity and polynucleotides encoding same |
10/09/2014 | WO2014161908A1 Brassica plants comprising mutant da1 alleles |
10/09/2014 | WO2014161821A1 Targeted genome engineering in eukaryotes |
10/09/2014 | WO2014161712A1 Novel dna-ploymerases |
10/09/2014 | WO2014161509A1 Novel pd1 isoforms, and uses thereof for potentiating immune responses |
10/09/2014 | WO2014161483A1 Broad spectrum monoclonal antibody identifying ha1 structural domain of influenza virus hemagglutinin proteins |
10/09/2014 | WO2014161405A1 Means and method for expression of authentic human epidermal growth factor and/or basic fibrolast growth factor in cytoplasm and/or culture medium of escherichia coli |
10/09/2014 | WO2014161284A1 Cell-penetrating polypeptides and uses thereof in drug delivery |
10/09/2014 | WO2014161095A1 Crp40 fragments for the treatment of neurological disorders |
10/09/2014 | WO2014039970A9 Fluorescence activated cell sorting (facs) enrichment to generate plants |
10/09/2014 | US20140304858 Plants having enhanced yield-related traits and producing methods thereof |
10/09/2014 | US20140304857 Maize stress related transcription factor 18 and uses thereof |
10/09/2014 | US20140304856 Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding pae and pae-like polypeptides |
10/09/2014 | US20140304854 Methods for the identification of genes involved in abiotic stress tolerance in plants |
10/09/2014 | US20140304853 Methods and compositions for integration of an exogenous sequence within the genome of plants |
10/09/2014 | US20140304852 Novel ppetac1 gene and method to manipulate tree architecture |
10/09/2014 | US20140304851 Oat plants having increased beta-glucan levels |
10/09/2014 | US20140304849 Corn event pv-zmgt32(nk603) and compositions and methods for detection thereof |
10/09/2014 | US20140304848 Genes and uses for plant improvement |
10/09/2014 | US20140304847 Recombination efficiency by inhibition of nhej dna repair |
10/09/2014 | US20140303362 Reduction of off-target rna interference toxicity |
10/09/2014 | US20140303352 Genes that increase plant oil and method for using the same |
10/09/2014 | US20140303351 Genes that increase plant oil and method for using the same |
10/09/2014 | US20140303350 Genes that increase plant oil and method for using the same |
10/09/2014 | US20140303349 Genes that increase plant oil and method for using the same |
10/09/2014 | US20140303238 Oligonucleotides for treating expanded repeat diseases |
10/09/2014 | US20140303237 Auto-recognizing therapeutic rna/dna chimeric nanoparticles (np) |
10/09/2014 | US20140303236 Control of whole body energy homeostasis by microrna regulation |
10/09/2014 | US20140303235 Linkage modified gapped oligomeric compounds and uses thereof |
10/09/2014 | US20140303234 Methods for the modulation of angiogenesis |
10/09/2014 | US20140303233 ANTISENSE OLIGONUCLEOTIDES AGAINST cPLA2, COMPOSITIONS AND USES THEREOF |
10/09/2014 | US20140303232 Lipids and lipid compositions for the delivery of active agents |
10/09/2014 | US20140303231 Methods and compositions for treating or preventing pruritis |
10/09/2014 | US20140303230 Pharmaceutical composition comprising nanog shrna, and method of using nanog shrna to treat cancer |
10/09/2014 | US20140303077 Albumin fusion proteins |
10/09/2014 | US20140303073 Antisense antiviral compound and method for treating influenza viral infection |
10/09/2014 | US20140303036 Nucleic Acid Assembly System |
10/09/2014 | US20140303017 Multiplexed Amplification of Short Nucleic Acids |
10/09/2014 | US20140303009 Compositions, Methods, and Kits for Identifying Candidate Molecules from Encoded Chemical Libraries |
10/09/2014 | US20140303005 Rare cell analysis after negative selection |
10/09/2014 | US20140303004 Method for exclusive selection of circularized dna from monomolecular dna in circularizing dna molecules |
10/09/2014 | US20140303000 Compositions and methods for directional nucleic acid amplification and sequencing |
10/09/2014 | US20140302998 Akt-specific capture agents, compositions, and methods of using and making |
10/09/2014 | US20140302609 Polydnavirus delivery constructs |
10/09/2014 | US20140302608 Modified Effector Cell (or Chimeric Receptor) for Treating Disialoganglioside GD2-Expressing Neoplasia |
10/09/2014 | US20140302607 Polymer based polynucleotide transfection agents |
10/09/2014 | US20140302603 Chimeric double-stranded nucleic acid |
10/09/2014 | US20140302600 Primate pluripotent stem cell expansion without feeder cells and in the presence of fgf and matrigel or engelbreth-holm-swarm tumor cell preaparation |
10/09/2014 | US20140302584 Novel variant hypocrea jecorina cbh1 cellulase |
10/09/2014 | US20140302583 Genetically inducible hydrogen peroxide resistance and production |
10/09/2014 | US20140302577 Enhanced yeast fermentation platform using yeast lacking mitochondrial dna and containing growth improving mutations |
10/09/2014 | US20140302574 3-hydroxypropionic acid and other organic compounds |
10/09/2014 | US20140302558 Modified bordetella pertussis strains |
10/09/2014 | US20140302556 Controlling o-glycosylation in lower eukaryotes |
10/09/2014 | US20140302555 Reduced Genome Bacteria With Improved Genetic Stability |
10/09/2014 | US20140302499 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
10/09/2014 | US20140302145 Pharmaceutical composition for treating cancer using carbonate apatite nanoparticles |
10/09/2014 | US20140302119 Microvesicles carrying small interfering rnas preparation methods and uses thereof |
10/09/2014 | US20140302098 Yeast-based vaccines as immunotherapy |
10/09/2014 | US20140302096 Compositions for the preparation of mature dendritic cells |
10/09/2014 | US20140302059 Compositions and methods for cancer and cancer stem cell detection and elimination |
10/09/2014 | US20140302057 Inhibitors of metastasis |
10/09/2014 | US20140302044 Mcpip protection against osteoclast production |
10/09/2014 | US20140302023 Use of rank/rankl antagonists for treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies and/or for regulating skeletal and cardiac muscle disuse, diseases and aging |
10/09/2014 | US20140301997 Composition for a mitotic remodeling of chromosomes |
10/09/2014 | US20140301991 Methods for Generating Cardiomyocytes |
10/09/2014 | US20140301990 Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases |
10/09/2014 | US20140301989 Methods for increasing the potency and efficacy of stem cells |
10/09/2014 | US20140301982 Complement antagonists and uses thereof |
10/09/2014 | US20140301943 Induction of thyroid iodide-handling gene expression in human cancers |
10/08/2014 | EP2787346A1 Biomarker for lymphocytic infundibuloneurohypophysitis, and use applications thereof |
10/08/2014 | EP2787082A1 Microorganism for simultaneously producing l-amino acid and riboflavin, and method for producing l-amino acid and riboflavin using same |
10/08/2014 | EP2787081A1 Drug containing carrier into cell for forming immune complex |
10/08/2014 | EP2787080A1 Promoter derived from human gene |
10/08/2014 | EP2787079A1 IgA-BINDING PEPTIDE AND PURIFICATION OF IgA THEREBY |
10/08/2014 | EP2787078A1 Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain |
10/08/2014 | EP2787077A1 Method for detecting target nucleic acid |
10/08/2014 | EP2787076A1 Method for evaluating drug sensitivity and susceptibility to diseases by analyzing gene for protein capable of binding to cyclic-amp-responsive sequence |
10/08/2014 | EP2787075A1 Rodent capable of producing hybrid antibodies containing human variable regions and rodent constant regions |
10/08/2014 | EP2787068A1 Base for use in amplification of nucleic acid, and nucleic acid amplification method |
10/08/2014 | EP2787067A1 Liquid reflux high-speed gene amplification device |
10/08/2014 | EP2787004A1 A method for predicting a "mantled" phenotype in oil palm plants and minimizing the percentage of oil palm plants with a "mantled" phenotype in a culture, and polynucleotide to be used therein |
10/08/2014 | EP2786146A1 High throughput single nucleotide polymorphism assay |
10/08/2014 | EP2785874A1 Personalized pain management and anesthesia: preemptive risk identification and therapeutic decision support |
10/08/2014 | EP2785870A1 Smyd2 as a target gene for cancer therapy and diagnosis |
10/08/2014 | EP2785845A2 Functional isotype switching of chimaeric antibody chains & chimaeric animals expressing different igh isotypes |
10/08/2014 | EP2785844A1 Polypeptide |
10/08/2014 | EP2785843A1 Novel enhanced selectin antagonists |
10/08/2014 | EP2785842A1 Hpv chimaeric particle |
10/08/2014 | EP2785841A2 Anti-fh aptamers, method for producing same, and uses thereof |